A recombinant protein antigen with a N-terminal His6-ABP tag corresponding to human IRF2BPL.
Points forts
Amino Acid Sequence
SLRKRKASPEPPDSAEGALKLGEEQQRQQWMANQSEALKLTMSAG The IRF2BPL Recombinant Protein Antigen is derived from E. coli. The IRF2BPL Recombinant Protein Antigen has been validated for the following applications: Antibody Competition.
Caractéristiques techniques
| Marque | Novus Biologicals |
|---|
| Réf. B-LABO | BL-RE-052943 |
|---|
| Réf. fabricant | 18266715 |
|---|
| Gene ID (Entrez) | 64207 |
|---|
| Méthode de purification | >80% by SDS-PAGE and Coomassie blue staining |
|---|
| Nom usuel | IRF2BPL Recombinant Protein Antigen |
|---|
| Contenu et stockage | Store at −20°C. Avoid freeze-thaw cycles. |
|---|
| Formule | PBS and 1M Urea, pH 7.4. |
|---|
| À utiliser avec (application) | Blocking/Neutralizing, Control |
|---|
| Alias de gène | C14orf4, EAP1, IRF2BPL interferon regulatory factor 2 binding protein-like |
|---|
| Symbole de gène(s) | IRF2BPL |
|---|
| Type d’étiquette | Unlabeled |
|---|
| Type de produit | Recombinant Protein Antigen |
|---|
| Quantité | 100μL |
|---|
| État réglementaire | RUO |
|---|
| Source | E.Coli |
|---|
| Réactivité spécifique | This recombinant antigen is only intended to be used as a blocking agent to confirm antibody specificity with the corresponding antibody, catalog number NBP2-50474. It is purified by IMAC chromatography, and the expected concentration is greater than 0.5 mg/ml |
|---|
Une question, une configuration particulière ?
Contactez-nous pour un devis.
